IFN-γ dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 225-233

  Coley, Shana M ^a   Ford, Mandy L ^a   Hanna, Samantha C ^a   Wagener, Maylene E ^a   Kirk, Allan D ^a   Larsen, Christian P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ABATACEPT; ANTIBODY CONJUGATE; CD40 LIGAND; GAMMA INTERFERON RECEPTOR; IMMUNOSUPPRESSIVE AGENT; INTERFERON RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNITY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SKIN TRANSPLANTATION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERFERON; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 59849108647     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.225     Document Type: Article

References (52)

1. Jenkins, M. K., J. D. Ashwell, and R. H. Schwartz. 1988. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140: 3324-3330.
2. Vincenti, F. 2008. Costimulation blockade in autoimmunity and transplantation. J. Allergy Clin. Immunol. 121: 299-308.
3. Fox, C. J., P. S. Hammerman, and C. B. Thompson. 2005. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5: 844-852.
4. Elster, E. A., D. A. Hale, R. B. Mannon, L. C. Cendales, S. J. Swanson, and A. D. Kirk. 2004. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transplant Immunol. 13: 87-99.
5. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438.
6. Williams, M. A., J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 2000. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol. 165: 6849-6857.
7. He, G., J. Hart, O. S. Kim, G. L. Szot, C. T. Siegel, J. R. Thistlethwaite, and K. A. Newell. 1999. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 67: 131-137.
8. + T cells play a critical role in costimulation blockaderesistant allograft rejection. J. Clin. Invest. 104: 1715-1722.
9. + T cell tolerance and linked suppression. J. Immunol. 163: 4805-4810.
10. Wheelock, E. F., and W. A. Sibley. 1965. Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus. N. Engl. J. Med. 273: 194-198.
11. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
12. Fountoulakis, M., M. Zulauf, A. Lustig, and G. Garotta. 1992. Stoichiometry of interaction between interferon gamma and its receptor. Eur. J. Biochem. 208: 781-787.
13. Bucy, R. P., D. W. Hanto, E. Berens, and R. D. Schreiber. 1988. Lack of an obligate role for IFN-γ in the primary in vitro mixed lymphocyte response. J. Immunol. 140: 1148-1152.
14. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005.
15. Hidalgo, L. G., J. Urmson, and P. F. Halloran. 2005. IFN-γ decreases CTL generation by limiting IL-2 production: a feedback loop controlling effector cell production. Am. J. Transplant. 5: 651-661.
16. Gajewski, T. F., and F. W. Fitch. 1988. Anti-proliferative effect of IFN-γ in immune regulation: I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140: 4245-4252.
17. + T cell homeostasis in the absence of IFN-γ signaling. J. Immunol. 178: 7616-7622.
18. + T cell memory. J. Immunol. 179: 1190-1197.
19. + T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
20. + cells and CD40-CD40 ligand interactions. J. Immunol. 166: 3248-3255.
21. Kishimoto, K., S. Sandner, J. Imitola, M. Sho, Y. Li, P. B. Langmuir, D. M. Rothstein, T. B. Strom, L. A. Turka, and M. H. Sayegh. 2002. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J. Clin. Invest. 109: 1471-1479.
22. Konieczny, B. T., Z. Dai, E. T. Elwood, S. Saleem, P. S. Linsley, F. K. Baddoura, C. P. Larsen, T. C. Pearson, and F. G. Lakkis. 1998. IFN-γ is critical for longterm allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160: 2059-2064.
23. Hassan, A. T., Z. Dai, B. T. Konieczny, G. H. Ring, F. K. Baddoura, L. H. Abou-Dahab, A. A. El-Sayed, and F. G. Lakkis. 1999. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: implications for long-term allograft acceptance. Transplantation 68: 124-129.
24. Halloran, P. F., M. Afrouzian, V. Ramassar, J. Urmson, L. F. Zhu, L. M. Helms, K. Solez, and N. M. Kneteman. 2001. Interferon-γ acts directly on rejecting renal allografts to prevent graft necrosis. Am. J. Pathol. 158: 215-226.
25. Halloran, P. F., L. W. Miller, J. Urmson, V. Ramassar, L. F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian. 2001. IFN-γ alters the pathology of graft rejection: protection from early necrosis. J. Immunol. 166: 7072-7081.
26. Mele, T. S., N. M. Kneteman, L. F. Zhu, V. Ramassar, J. Urmson, B. Halloran, T. A. Churchill, L. Jewell, K. Kane, and P. F. Halloran. 2003. IFN-γ is an absolute requirement for spontaneous acceptance of liver allografts. Am. J. Transplant. 3: 942-951.
27. Miura, M., T. El-Sawy, and R. L. Fairchild. 2003. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-γ. Am. J. Pathol. 162: 509-519.
28. + regulatory T cells by induction of IDO in endothelial cells. Am. J. Transplant. 7: 2472-2482.
29. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
30. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
31. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
32. Sawitzki, B., C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood. 2005. IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201: 1925-1935.
33. Brehm, M. A., J. Mangada, T. G. Markees, T. Pearson, K. A. Daniels, T. B. Thornley, R. M. Welsh, A. A. Rossini, and D. L. Greiner. 2007. Rapid quantification of naive alloreactive T cells by TNF-α production and correlation with allograft rejection in mice. Blood 109: 819-826.
34. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
35. Guillonneau, C., M. Hill, F. X. Hubert, E. Chiffoleau, C. Hervé, X. L. Li, M. Heslan, C. Usal, L. Tesson, S. Ménoret, et al. 2007. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-γ, and indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 1096-1106.
36. Whitmire, J. K., R. A. Flavell, I. S. Grewal, C. P. Larsen, T. C. Pearson, and R. Ahmed. 1999. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J. Immunol. 163: 3194-3201.
37. Famulski, K. S., B. Sis, L. Billesberger, and P. F. Halloran. 2008. Interferon-γ and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am. J. Transplant. 8: 547-556.
38. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ. Arthritis Res. Ther. 7: R402-R415.
39. Fukushima, A., K. Fukata, A. Ozaki, M. Takata, N. Kuroda, H. Enzan, and H. Ueno. 2002. Exertion of the suppressive effects of IFN-γ on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br. J. Ophthalmol. 86: 1166-1171.
40. Wheeler, R. D., and T. Owens. 2005. The changing face of cytokines in the brain: perspectives from EAE. Curr. Pharm. Des. 11: 1031-1037.
41. Lin, W., S. L. Bailey, H. Ho, H. P. Harding, D. Ron, S. D. Miller, and B. Popko. 2007. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117: 448-456.
42. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893-895.
43. + Tregs. J. Clin. Invest. 116: 2434-2441.
44. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152: 5208-5219.
45. Isakov, N., and A. Altman. 2002. Protein kinase C(θ) in T cell activation. Annu. Rev. Immunol. 20: 761-794.
46. Srivastava, K. K., S. Batra, A. Sassano, Y. Li, B. Majchrzak, H. Kiyokawa, A. Altman, E. N. Fish, and L. C. Platanias. 2004. Engagement of protein kinase C-θ in interferon signaling in T-cells. J. Biol. Chem. 279: 29911-29920.
47. + T cells. J. Immunol. 175: 5126-5134.
48. + effector T cells reject tumors by direct antigen recognition but indirect action on host cells. J. Immunol. 170: 4427-4431.
49. + T cell-mediated rejection of pancreatic islet allografts. J. Immunol. 165: 247-255.
50. + T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3: 844-851.
51. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
52. van Boxel-Dezaire, A. H., and G. R. Stark. 2007. Cell type-specific signaling in response to interferon-γ. Curr. Top. Microbiol. Immunol. 316: 119-154.